- Home
- WDH vs RGNX Comparison
WDH vs RGNX Comparison
Compare WDH & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WDH | RGNX |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 647.4M | 732.0M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | WDH | RGNX |
|---|---|---|
| Price | $1.90 | $13.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $30.78 |
| AVG Volume (30 Days) | 413.0K | ★ 705.2K |
| Earning Date | 12-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 75.20 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $456,980,701.00 | $161,318,000.00 |
| Revenue This Year | N/A | $132.80 |
| Revenue Next Year | $12.60 | $45.32 |
| P/E Ratio | $9.66 | ★ N/A |
| Revenue Growth | 18.55 | ★ 91.30 |
| 52 Week Low | $1.08 | $5.04 |
| 52 Week High | $2.18 | $15.41 |
Technical Indicators
Market Signals| Indicator | WDH | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 49.74 |
| Support Level | $1.80 | $13.66 |
| Resistance Level | $1.94 | $14.65 |
| Average True Range (ATR) | 0.09 | 0.92 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 62.00 | 24.02 |
Price Performance
Historical ComparisonAbout WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.